Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Warsaw
Clinical trial register · Poland

Clinical Trials in Warsaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2709 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2709
Studies in scope
all four open statuses
1380
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 1318 Krakow 881 Poznan 697 Gdansk 663 Lodz 618
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca95 Merck Sharp & Dohme LLC87 Medical University of Warsaw68 Hoffmann-La Roche60 Janssen Research & Development, LLC44 AbbVie39 Eli Lilly and Company36 Pfizer31 Bristol-Myers Squibb30 Novartis Pharmaceuticals28 Takeda25 Sanofi23 Novo Nordisk A/S22 Amgen21 Boehringer Ingelheim17 GlaxoSmithKline17 argenx14 Incyte Corporation14 European Organisation for Research and Treatment of Cancer - EORTC14 Alexion Pharmaceuticals, Inc.11 Bayer10 Celgene10 National Institute of Cardiology, Warsaw, Poland9 UCB Biopharma SRL9 Regeneron Pharmaceuticals8 Show all 417
Site location
Warsaw1318 Krakow881 Poznan697 Gdansk663 Lodz618 Wroclaw526 Bydgoszcz525 Lublin525 Katowice510 Bialystok388 Olsztyn190 Rzeszów183 Szczecin183 Gdynia167 Gliwice121 Kielce117 Torun111 Opole106 Koszalin84 Siedlce81 Zabrze69 Elblag67 Otwock56 Przemyśl55 Chorzów53 Show all 264
All 264 locations
Target enrolment
to

Trials with a site in Warsaw

1318 of 2709 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Warsaw, Gdansk, Poznan
2027-11-23
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Bialystok, Chorzów, Piaseczno, Rzeszów, Świdnik, Warsaw, Wroclaw
2027-01-11
Not yet open
MediWound Ltd
Phase 2
45
Warsaw
2027-01-10
Not yet open
GOAt Milk Formula-based Ladder Versus Cow's Milk Ladder
NCT07795957Food Allergy, Cow's Milk Protein Allergy, Cow's Milk Allergy
Medical University of Warsaw
Not applicable
92
Lodz, Warsaw
2027-01-02
Not yet open
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
NCT07471230Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere
Biocells Medical
Phase 2
120
Warsaw
2026-11-23
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Grodzisk Mazowiecki, Ostrów Mazowiecka, Warsaw, Gdynia, Elblag, Gdansk, Krakow, Lodz
2026-11-11
Not yet open
Amgen
Phase 2
15
Warsaw
2026-10-31
By invitation
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
NCT07604883PARKINSON DISEASE (Disorder), Atypical Parkinsonism, Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
International Institute of Molecular and Cell Biology in Warsaw
Observational
200
Warsaw
2026-10-30
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Lublin, Gorzów Wielkopolski, Grodzisk Mazowiecki, Ostrów Mazowiecka, Warsaw, Bialystok, Częstochowa, Bielsko-Biala
2026-10-26
Not yet open
RBD1119 in Coronary Artery Disease (CAD)
NCT07884136Stable Coronary Artery Disease
DrugRBD1119
Ribocure Pharmaceuticals AB
Phase 2
200
Gdynia, Grodzisk Mazowiecki, Krakow, Lubin, Lublin, Warsaw, Zamość
2026-10-16
Recruiting
Novo Nordisk A/S
Phase 3
84
Gdansk, Lodz, Poznan, Warsaw
2026-10-16
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Warsaw
2026-10-07
Recruiting
Bristol-Myers Squibb
Phase 3
176
Poznan, Wroclaw, Warsaw, Gdansk, Szczecin, Katowice, Lublin, Zabrze
2026-10-06
Recruiting
Hoffmann-La Roche
Phase 3
400
Bystra, Gda?sk, Kielce, Olsztyn, Warsaw, Wroc?aw
2026-10-06
Not yet open
Vortosiran in Atrial Fibrillation
NCT07870889Non-valvular Atrial Fibrillation (AF)
DrugsVortosiran·Apixaban
Ribocure Pharmaceuticals AB
Phase 2
150
Katowice, Krakow, Raszyn, Skorzewo, Warsaw, Wroclaw
2026-10-01
Not yet open
Zoll Medical Corporation
Not applicable
800
Warsaw
2026-10-01
Not yet open
Internet Intervention for Well-Being and Work-Family Conflict in Dual-Earner Couples
NCT07845799Psychological Stress, Work-Family Conflict, Family-Work Conflict
University of Social Sciences and Humanities, Warsaw
Not applicable
564
Warsaw
2026-10
Recruiting
Arrowhead Pharmaceuticals
Phase 3
10
Warsaw
2026-10
Recruiting
Faron Pharmaceuticals Ltd
Phase 2
90
Katowice, Skórzewo, Warsaw
2026-10
Recruiting
Eli Lilly and Company
Phase 3
150
Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Warszewo, Wroclaw
2026-09-25
Recruiting
Akeso
Phase 3
900
Krakow, Poznan, Warsaw
2026-09-24
Recruiting
Takeda
Observational
94
Krakow, Lodz, Warsaw, Zabrze
2026-09-24
Recruiting
Boehringer Ingelheim
Phase 3
466
Gdansk, Świdnik, Warsaw
2026-09-17
Recruiting
AstraZeneca
Phase 3
1,330
Gdansk, Koszalin, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2026-09-15
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Skórzewo, Krakow, Wroclaw, Otwock, Siedlce, Warsaw, Opole, Przemyśl
2026-09-11
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Bielsko-Biala, Bydgoszcz, Katowice, Krakow, Olsztyn, Poznan, Warsaw, Wałbrzych
2026-09-11
Recruiting
Takeda
Phase 3
324
Poznan, Torun, Krakow, Warsaw, Chorzów, Katowice, Lodz
2026-09-10
Recruiting
Incyte Corporation
Phase 3
426
Gdansk, Katowice, Krakow, Lodz, Warsaw, Wałbrzych
2026-09-08
Recruiting
AstraZeneca
Phase 3
2,800
Olsztyn, Warsaw, Węgrów, Wroclaw, Żywiec
2026-09-01
Not yet open
Autologous Stem Cell Therapy in Patients With Multiple System Atrophy
NCT07465198MSA - Multiple System Atrophy, MSA
Biocells Medical
Phase 2
50
Warsaw
2026-09-01
Not yet open
Universidad Complutense de Madrid
Phase 4
82
Warsaw
2026-09-01
Not yet open
Medical University of Warsaw
Not applicable
270
Warsaw
2026-09-01
By invitation
Applications of a Functional Dairy Product in Diet Therapy
NCT07793487Metabolic Syndrome, IBS - Irritable Bowel Syndrome
Warsaw University of Life Sciences
Not applicable
80
Warsaw
2026-09
Not yet open
Multi-Food Oral Immunotherapy for Peanut and Tree Nuts
NCT07764159Food Allergies, Food Allergy in Children, Peanut Allergies, Tree Nut Allergies
Medical University of Warsaw
Not applicable
39
Poznan, Krakow, Dziekanów Leśny, Warsaw
2026-09
Not yet open
Bożenna Dembowska Bagińska
Phase 1
48
Warsaw
2026-09
Recruiting
AstraZeneca
Phase 3
1,072
Bydgoszcz, Katowice, Kielce, Krakow, Lodz, Ossy, Warsaw
2026-08-31
Recruiting
Kardigan, Inc.
Phase 3
332
Gdansk, Krakow, Lodz, Warsaw
2026-08-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
472
Warsaw, Bialystok, Poznan
2026-08-20
Recruiting
Takeda
Observational
110
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Opole, Przemyśl, Bialystok
2026-08-13
Recruiting
AstraZeneca
Phase 3
600
Częstochowa, Gdynia, Katowice, Lodz, Lublin, Warsaw
2026-08-12
Recruiting
Novo Nordisk A/S
Phase 3
450
Bialystok, Bydgoszcz, Bygdoszcz, Lodz, Poznan, Staszów, Warsaw
2026-08-12
Recruiting
Imageless Navigation Versus Image-Based Navigation in Robotic-Assisted Total Knee Arthroplasty for Knee Osteoarthritis
NCT07522489Osteoarthritis (OA) of the Knee, Knee Pain Arthritis, Total Knee Arthroplasty (TKA), Robotic Assisted Arthroplasty
Medical University of Warsaw
Not applicable
146
Warsaw
2026-08-06
Recruiting
Xyra, LLC
Phase 2
100
Gdynia, Krakow, Rzeszów, Warsaw
2026-08-06
Recruiting
Eli Lilly and Company
Phase 4
14
Radom, Warsaw
2026-08-05
Recruiting
Mitera Hospital
Not applicable
292
Warsaw
2026-08-01
Not yet open
Medical University of Warsaw
Observational
240
Warsaw
2026-08-01
Not yet open
Medical University of Warsaw
Not applicable
30
Warsaw, Bialystok, Szczecin
2026-08-01
Recruiting
Boston Scientific Corporation
Not applicable
200
Warsaw
2026-07-28
Recruiting
Boehringer Ingelheim
Phase 3
448
Bialystok, Bydgoszcz, Krakow, Poznan, Warsaw
2026-07-27
Recruiting
GlaxoSmithKline
Phase 3
800
Warsaw
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
35
Warsaw
2026-07-21
Recruiting
Efficacy of Platelet-Rich Plasma Added to Hyaluronic Acid in Knee Osteoarthritis
NCT07785401Knee Osteoarthritis, Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA), Osteoarthritis (OA) of the Knee
Implai Sp z o.o
Not applicable
50
Warsaw
2026-07-20
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Warsaw
2026-07-10
Recruiting
QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease (The QUIET Trial)
NCT07700342Nocturnal Symptoms of GERD, Sleep Disorders in GERD, GERD (Gastroesophageal Reflux Disease), Non-Erosive Gastro-Esophageal Reflux Disease
Cellmedis
Not applicable
50
Warsaw
2026-07-09
Recruiting
AstraZeneca
Phase 3
600
Bialystok, Częstochowa, Kielce, Krakow, Lodz, Poznan, Radom, Warsaw
2026-07-08
Recruiting
Centre of Postgraduate Medical Education
Not applicable
80
Warsaw
2026-07-07
Recruiting
AstraZeneca
Phase 3
1,200
Bialystok, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
Centre of Postgraduate Medical Education
Not applicable
80
Warsaw
2026-07-01
Recruiting
TG Therapeutics, Inc.
Phase 2/3
240
Gdansk, Poznan, Rzeszów, Warsaw
2026-07-01
Recruiting
Medical University of Warsaw
Not applicable
240
Warsaw
2026-07-01
Recruiting
Prilenia
Phase 3
400
Krakow, Warsaw
2026-07-01
Recruiting
Hoffmann-La Roche
Phase 1
25
Bydgoszcz, Lodz, Lublin, Nowy Targ, Pabianice, Późna, Warsaw, Wroc?aw
2026-06-29
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Gdansk, Gliwice, Lodz, Opole, Poznan, Szczecin, Warsaw
2026-06-26
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730Atypical Hemolytic Uremic Syndrome
DrugRavulizumab
AstraZeneca
Observational
80
Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2026-06-24
Recruiting
Hoffmann-La Roche
Phase 3
380
Krakow, Gda?sk, Późna, Szczecin, Warsaw, Wroc?aw
2026-06-23
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606B-cell Non Hodgkin Lymphoma
DrugRituximab
Taiho Oncology, Inc.
Phase 1
140
Katowice, Krakow, Skorzewo, Warsaw
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Krakow, Warsaw
2026-06-22
Recruiting
Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance
NCT07855679Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension, Right Ventricular Dysfunction, Pulmonary Embolism (PE)
Azienda Ospedaliero-Universitaria Careggi
Observational
5,000
Warsaw
2026-06-19
Recruiting
Medical University of Gdansk
Not applicable
480
Gdansk, Warsaw
2026-06-14
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Bialystok, Krakow, Lodz, Poznan, Rzeszów, Warsaw
2026-06-11
Recruiting
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
NCT07220915Hypogammaglobulinemia, Autoimmune Conditions, Rheumatic Conditions, Infections
DrugPanzyga
Octapharma
Phase 3
360
Gdansk, Warsaw
2026-06-10
Recruiting
argenx
Phase 3
230
Krakow, Katowice, Bydgoszcz, Chrzanów, Lublin, Warsaw, Zamość
2026-06-10
Not yet open
Mental Rehearsal in Emergency Cricothyroidotomy Training
NCT07625072Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy
Medical University of Warsaw
Not applicable
60
Warsaw
2026-06-08
Recruiting
AstraZeneca
Phase 2
80
Bydgoszcz, Krakow, Lodz, Lublin, Warsaw
2026-06-04
Recruiting
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
NCT06494878Venous Thromboembolism, Postpartum Period, Aspirin, Low Molecular Weight Heparin
DrugsDalteparin·Tinzaparin·Low molecular weight heparin·Enoxaparin
University of Calgary
Phase 3
8,805
Warsaw
2026-06-04
Recruiting
Hoffmann-La Roche
Phase 2
120
Warsaw, Bytom, Elblag, Lublin, Nowa Sól, Wroclaw
2026-06-03
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Lublin, Warsaw, Katowice
2026-06-02
By invitation
The Importance of Mucosal Screening in the Prevention of Oral Cancer.
NCT07682883OPMD, Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer, Oral Potentially Malignant Lesions, Leukoplakia Oral
Medical University of Warsaw
Not applicable
1,383
Warsaw
2026-06-01
Not yet open
Biocells Medical
Phase 1/2
90
Warsaw
2026-06-01
Recruiting
Bayer
Phase 3
117
Wroclaw, Warsaw, Gdansk, Katowice, Lodz
2026-06-01
Not yet open
CardioNETPOL National Registry of Carcinoid Heart Disease
NCT07450287Carcinoid Heart Disease, Neuroendocrine Tumors, Carcinoid Syndrome, Valvular Heart Disease Patients
National Institute of Cardiology, Warsaw, Poland
Observational
120
Warsaw
2026-06-01
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bydgoszcz, Gdansk, Katowice, Lublin, Warsaw, Wałbrzych
2026-05-31
Recruiting
Pfizer
Phase 2
24
Warsaw, Katowice
2026-05-28
Recruiting
New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)
NCT07624383GERD (Gastroesophageal Reflux Disease), NERD, Heartburn, Regurgitation, Gastric
Cellmedis
Not applicable
50
Warsaw
2026-05-28
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Gdansk, Katowice, Lublin, Skorzewo, Torun, Warsaw, Wałbrzych
2026-05-27
Recruiting
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
NCT07519057Liver Transplantation, Liver Transplant, Liver Transplant Surgery, End Stage Liver Disease
Medical University of Warsaw
Not applicable
434
Warsaw
2026-05-27
Recruiting
UCB Biopharma SRL
Phase 3
120
Katowice, Krakow, Lublin, Warsaw
2026-05-27
Recruiting
Genetic, Microbiological and Behavioral Factors in Obesity
NCT07650149Obesity & Overweight, Obesity, Genetics
Jan Kochanowski University
Observational
200
Krakow, Warsaw
2026-05-23
Recruiting
BeOne Medicines
Phase 3
1,056
Bialystok, Gdynia, Kielce, Krakow, Opole, Otwock, Warsaw
2026-05-22
Recruiting
Takeda
Phase 3
300
Wroclaw, Krakow, Warsaw, Katowice, Skorzewo
2026-05-21
Recruiting
Alfasigma S.p.A.
Phase 3
65
Bydgoszcz, Torun, Warsaw
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bialystok, Bydgoszcz, Dębica, Katowice, Krakow, Poznan, Rzeszów, Warsaw
2026-05-21
Recruiting
Józef Piłsudski University of Physical Education
Observational
90
Warsaw
2026-05-16
Recruiting
Ipsen
Phase 3
350
Lublin, Mysłowice, Warsaw
2026-05-14
Recruiting
Almirall, S.A.
Phase 2
50
Warsaw
2026-05-13
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 2
34
Bydgoszcz, Katowice, Poznan, Warsaw
2026-05-13
Recruiting
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
NCT07370649Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection, Virologically Suppressed HIV-1 Infection Receiving Long-Acting Antiretroviral Therapy
DrugCabotegravir
Pomeranian Medical University Szczecin
Observational
250
Szczecin, Bydgoszcz, Gdansk, Warsaw, Wroclaw
2026-05-12
Recruiting
Assessment of LVOT VTI in Healthy Volunteers
NCT07600931Hemodynamic Assessment, Bedside Ultrasonography, Point of Care Ultrasound (POCUS)
Medical University of Warsaw
Observational
30
Warsaw
2026-05-11
Recruiting
Amgen
Phase 2
30
Warsaw
2026-05-07
Recruiting
Hoffmann-La Roche
Phase 3
8
Gdansk, Warsaw
2026-05-06
Recruiting
AstraZeneca
Observational
2,150
Lublin, Krakow, Radom, Bialystok, Częstochowa, Poznan, Warsaw, Lodz
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
531
Katowice, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Zamość
2026-05-06
Recruiting
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Early Phase 1
90
Warsaw
2026-05-06
Recruiting
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
Grifols Therapeutics LLC
Phase 3
40
Warsaw
2026-05-05
Recruiting
AstraZeneca
Phase 3
670
Gdansk, Krakow, Warsaw
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Poznan, Warsaw, Lodz, Chęciny
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Katowice, Krakow, Lublin, Poznan, Siedlce, Szczecin, Warsaw, Zamość
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Katowice, Krakow, Lublin, Poznan, Siedlce, Szczecin, Warsaw, Zamość
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Krakow, Warsaw, Gliwice, Katowice
2026-05-03
Recruiting
Enlivex Therapeutics Ltd.
Phase 2
182
Bytom, Katowice, Krakow, Poznan, Radom, Swidnica, Warsaw, Wroclaw
2026-05-01
Recruiting
BioNTech SE
Phase 3
736
Krakow, Warsaw
2026-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Bydgoszcz, Krakow, Rzeszów, Szczecin, Torun, Warsaw
2026-04-21
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 3
20
Krakow, Warsaw
2026-04-21
Recruiting
Boehringer Ingelheim
Phase 2
405
Bydgoszcz, Krakow, Poznan, Warsaw, Wroclaw
2026-04-20
Active, closed
Merck Sharp & Dohme LLC
Phase 2
140
Bydgoszcz, Torun, Lublin, Warsaw
2026-04-20
Recruiting
Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.
NCT07555314Midline Catheter, Lidocaine Infusion, Chronic Pain, Outpatient
Medical University of Warsaw
Observational
500
Warsaw
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 3
400
Bialystok, Bydgoszcz, Krakow, Warsaw
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 2
270
Bialystok, Lublin, Oświęcim, Warsaw, Zabrze
2026-04-17
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
DrugRituximab
Eli Lilly and Company
Phase 1
460
Katowice, Krakow, Skorzewo, Warsaw
2026-04-17
Recruiting
Mediar Therapeutics
Phase 2
85
Bydgoszcz, Nowa Sól, Warsaw
2026-04-16
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Katowice, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2026-04-16
Recruiting
Novo Nordisk A/S
Phase 3
400
Bialystok, Bydgoszcz, Krakow, Warsaw
2026-04-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Skórzewo, Krakow, Siedlce, Warsaw, Gliwice
2026-04-09
Recruiting
Incyte Corporation
Phase 3
588
Gdansk, Krakow, Warsaw, Wroclaw
2026-04-09
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
400
Poznan, Wroclaw, Warsaw, Gdansk, Szczecin, Katowice, Lublin, Zabrze
2026-04-07
Recruiting
MRM Health NV
Phase 2
204
Bydgoszcz, Katowice, Krakow, Poznan, Sopot, Warsaw, Wroclaw
2026-04-03
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Kraków, Szczecin, Warsaw
2026-04-01
Recruiting
GLSMED Learning Health S.A.
Observational
10,000
Warsaw
2026-04-01
Not yet open
PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)
NCT07498660Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total, Sacro-Iliac Spondylosis
Medical University of Warsaw
Not applicable
60
Warsaw
2026-04-01
Recruiting
Mage Biologics
Phase 1/2
100
Katowice, Warsaw, Wroclaw
2026-04-01
Recruiting
Anna Raciborska
Phase 2
40
Warsaw
2026-04-01
Recruiting
Michał Pasierbek
Not applicable
120
Wroclaw, Lublin, Warsaw, Krakow, Gdansk, Zabrze, Olsztyn, Kielce
2026-04-01
Recruiting
TG Therapeutics, Inc.
Phase 2
350
Bydgoszcz, Katowice, Kielce, Krakow, Lodz, Olsztyn, Poznan, Warsaw
2026-04-01
Recruiting
InRAD Observational Study
NCT07213700Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Non-Alzheimer Degenerative Dementia
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Observational
50,000
Warsaw
2026-03-30
Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study
NCT07288216Recurrent Pericarditis, Heart Diseases, Pericarditis
DrugKPL-387
Kiniksa Pharmaceuticals International, plc
Phase 2
120
Warsaw
2026-03-25
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Krakow, Wroclaw, Warsaw, Szczecin
2026-03-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Bydgoszcz, Warsaw
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Lodz, Poznan, Warsaw
2026-03-23
Recruiting
Zenas BioPharma (USA), LLC
Phase 3
990
Bydgoszcz, Lublin, Nowa Sól, Warsaw, Rzeszów, Katowice, Poznan, Szczecin
2026-03-23
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Wroclaw, Warsaw, Gdansk
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Warsaw, Opole, Jelenia Góra
2026-03-13
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
DrugEnpatoran
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Krakow, Lublin, Malbork, Rzeszów, Warsaw, Zamość
2026-03-10
Recruiting
Medical University of Warsaw
Not applicable
20
Warsaw
2026-03-09
Recruiting
Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation
NCT07232550Asthma in Children, Protracted Bacterial Bronchitis, Chronic Cough
Medical University of Warsaw
Observational
160
Warsaw
2026-03-06
Recruiting
Incyte Corporation
Phase 3
700
Jelenia Góra, Siedlce, Warsaw
2026-03-05
Recruiting
Nura Bio
Phase 1/2
80
Krakow, Warsaw
2026-03-04
Not yet open
Meta Self-efficacy Internet Intervention to Improve Work Self-efficacy and Occupational Well-being in Young Employees
NCT06944990Self Efficacy, Occupational Stress, Well-Being, Psychological, Work Related Stress
University of Social Sciences and Humanities, Warsaw
Not applicable
600
Warsaw
2026-03-01
Recruiting
Medical University of Warsaw
Not applicable
250
Warsaw
2026-03-01
Not yet open
COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus
NCT07462793Neonatal Hypoglycemia, Gestational Diabetes Mellitus (GDM)
Institute of Mother and Child, Warsaw, Poland
Not applicable
120
Warsaw
2026-03
Recruiting
AstraZeneca
Phase 3
508
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2026-02-23
Recruiting
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT07461220PARKINSON DISEASE (Disorder), Apathy, Safety
Integrative Research Laboratories AB
Phase 1/2
75
Bydgoszcz, Katowice, Lodz, Szczecin, Warsaw
2026-02-18
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Warsaw
2026-02-17
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
240
Bydgoszcz, Lublin, Olsztyn, Tarnów, Warsaw
2026-02-16
Recruiting
Boehringer Ingelheim
Phase 3
286
Krakow, Lodz, Poznan, Szczecin, Warsaw, Wroclaw
2026-02-16
Active, closed
Medical University of Warsaw
Not applicable
150
Warsaw
2026-02-14
Recruiting
Kardigan, Inc.
Phase 2/3
332
Gdansk, Krakow, Lodz, Warsaw
2026-02-13
Recruiting
Pfizer
Phase 2/3
1,156
Katowice, Krakow, Tarnów, Warsaw, Wroclaw, Ostrowiec Świętokrzyski
2026-02-11
Recruiting
Zealand Pharma
Phase 3
90
Lodz, Skawina, Warsaw
2026-02-11
Recruiting
GlaxoSmithKline
Phase 1
44
Poznan, Warsaw
2026-02-10
Active, closed
Corxel Pharmaceuticals
Phase 2
251
Poznan, Bydgoszcz, Krakow, Tarnów, Wroclaw, Lodz, Warsaw, Gdansk
2026-02-06
Recruiting
Eli Lilly and Company
Phase 3
300
Gdansk, Lodz, Warsaw, Wroclaw
2026-02-05
Recruiting
AstraZeneca
Phase 3
2,130
Gdansk, Koszalin, Krakow, Lublin, Olsztyn, Warsaw
2026-02-03
Recruiting
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
NCT07411690Brain Tumor Adult, Brain Tumor Benign, CerebroSpinal Fluid (CSF) Leak, Craniotomy
Medical University of Warsaw
Observational
200
Warsaw
2026-02-03
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
NCT06968845Idiopathic Pulmonary Fibrosis (IPF)
Rein Therapeutics
Phase 2
120
Nowa Sól, Lodz, Rzeszów, Warsaw, Sosnowiec
2026-02-02
Recruiting
Medical University of Warsaw
Not applicable
75
Warsaw
2026-02-02
Recruiting
Exciva GmbH
Phase 2/3
300
Poznan, Krakow, Wroclaw, Lublin, Sochaczew, Warsaw, Katowice, Zabrze
2026-02-02
Recruiting
Medical University of Warsaw
Not applicable
382
Warsaw
2026-02-01
Recruiting
Medical University of Warsaw
Not applicable
40
Warsaw
2026-02-01
Recruiting
Prilenia
Phase 3
500
Bydgoszcz, Krakow, Warsaw
2026-02-01
Not yet open
Breastmilk and the Link to Overweight/Obesity and Maternal Diet in the Mother-breastmilk-child Triad
NCT07457515Body Weight, Obesity & Overweight, Human Milk/Breastfeeding, Body Composition
Warsaw University of Life Sciences
Observational
165
Wroclaw, Warsaw
2026-02
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Warsaw
2026-01-29
By invitation
Immunovant Sciences GmbH
Phase 2
372
Bydgoszcz, Lublin, Warsaw, Kielce
2026-01-26
Active, closed
Takeda
Phase 2
91
Wroclaw, Warsaw, Rzeszów, Malbork
2026-01-26
Recruiting
IDEAYA Biosciences
Phase 3
520
Poznan, Warsaw, Gdansk
2026-01-25
Active, closed
CSL Behring
Phase 2
84
Warsaw, Wałbrzych, Wroclaw
2026-01-22
Recruiting
Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract
NCT07462000Primary Open-Angle Glaucoma (POAG), Cataract
Military Institute od Medicine National Research Institute
Not applicable
40
Warsaw
2026-01-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Warsaw, Gliwice, Siedlce, Kielce
2026-01-19
Active, closed
Differentiation of Human Body Balance Disorders
NCT07395180Stroke, Visual Defects, Labyrinth Diseases, Cervical Spine Degenerative Disease
Military Institute od Medicine National Research Institute
Not applicable
330
Warsaw
2026-01-19
Not yet open
Centre of Postgraduate Medical Education
Phase 4
216
Otwock, Warsaw
2026-01-15
Recruiting
Eli Lilly and Company
Phase 3
150
Warsaw
2026-01-12
Active, closed
Kailera
Phase 3
1,270
Bydgoszcz, Torun, Krakow, Lublin, Siedlce, Warsaw, Bialystok, Gdynia
2026-01-12
Active, closed
Hoffmann-La Roche
Phase 2
120
Katowice, Gdynia, Krakow, Rzeszów, Warsaw
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Bialystok, Krakow, Lublin, Warsaw
2026-01-07
Recruiting
Navigator Medicines, Inc.
Phase 2
150
Katowice, Kielce, Ossy, Warsaw, Wroclaw
2026-01-05
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Poznan, Krakow, Jelenia Góra, Warsaw, Wieliszew, Prabuty, Bydgoszcz
2026-01-02
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Rzeszów, Warsaw, Wroclaw, Zabrze
2026-01-01
Not yet open
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
NCT07160959Chronic Kidney Disease (Stages 4 and 5), Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l.
Not applicable
124
Warsaw
2026-01-01
Recruiting
Przychodnia Lekarska nOvum Katarzyna Kozioł, Piotr Lewandowski sp.k.
Not applicable
200
Warsaw
2026-01-01
Not yet open
Institute of Mother and Child, Warsaw, Poland
Not applicable
20
Warsaw
2026-01
Not yet open
Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control
NCT07376850Diabetes, Diabetes (DM), Diabetes Type 1
University Hospital, Motol
Not applicable
120
Warsaw
2026-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Krakow, Warsaw, Wieliszew, Opole, Brzozów, Gdansk, Gliwice, Koszalin
2025-12-31
Active, closed
Kailera
Phase 3
1,270
Krakow, Warsaw, Gdynia, Chorzów, Bydgoszcz, Wroclaw, Kielce
2025-12-30
Recruiting
Norgine
Phase 3
212
Torun, Krakow, Warsaw, Bialystok, Gdansk, Zabrze
2025-12-29
Active, closed
UCB Biopharma SRL
Phase 2
165
Chorzów, Katowice, Krakow, Lodz, Sosnowiec, Tarnów, Warsaw, Wroclaw
2025-12-29
Not yet open
Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
NCT07361666Basal Cell Carcinoma of Skin, Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Carcinoma in Situ (CSCCis), Cutaneous Squamous Cell Carcinoma of the Head and Neck
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Observational
400
Warsaw
2025-12-23
Recruiting
argenx
Phase 2
70
Bydgoszcz, Katowice, Warsaw
2025-12-19
Recruiting
argenx
Observational
70
Bydgoszcz, Krakow, Katowice, Warsaw
2025-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2
140
Warsaw
2025-12-19
Active, closed
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-12-19
Active, closed
Kailera
Phase 3
2,530
Poznan, Torun, Krakow, Siedlce, Warsaw, Skierniewice, Zamość
2025-12-18
Recruiting
Sanofi
Phase 3
85
Poznan, Wroclaw, Warsaw
2025-12-18
Recruiting
AstraZeneca
Phase 2
320
Krakow, Torun, Warsaw, Wroclaw
2025-12-15
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
180
Poznan, Warsaw, Przemyśl
2025-12-12
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Poznan, Warsaw, Lodz
2025-12-11
Active, closed
Zealand Pharma
Phase 3
28
Skawina, Warsaw, Lodz
2025-12-11
Active, closed
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
NCT07181590Paroxysmal AF, Atrial Arrhythmia, Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Warsaw
2025-12-11
Recruiting
Protara Therapeutics
Phase 2/3
129
Lodz, Warsaw
2025-12-10
Recruiting
AstraZeneca
Phase 2
230
Lublin, Warsaw
2025-12-10
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
DrugCYB003
Cybin IRL Limited
Phase 3
330
Bialystok, Bydgoszcz, Gdansk, Warsaw
2025-12-10
Recruiting
AbbVie
Phase 2/3
490
Poznan, Krakow, Warsaw, Gdansk, Sosnowiec
2025-12-10
Active, closed
Boehringer Ingelheim
Phase 3
135
Gdansk, Torun, Warsaw
2025-12-09
Recruiting
Hoffmann-La Roche
Phase 2
160
Bytom, Elbl?g, Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2025-12-05
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Warsaw, Koszalin
2025-12-04
Recruiting
AstraZeneca
Phase 3
1,100
Koszalin, Krakow, Lodz, Olsztyn, Warsaw
2025-12-04
Recruiting
Bristol-Myers Squibb
Phase 3
366
Lublin, Warsaw, Bialystok, Gdansk, Lodz, Olsztyn
2025-12-03
Active, closed
Ventus Therapeutics U.S., Inc.
Phase 2
24
Bialystok, Oświęcim, Poznan, Rzeszów, Śląskie, Warsaw, Wroclaw
2025-12-03
Recruiting
GlaxoSmithKline
Phase 3
450
Kielce, Poznan, Warsaw
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Gdansk, Gliwice, Lodz, Lublin, Poznan, Warsaw
2025-12-03
Recruiting
Pfizer
Phase 3
450
Krakow, Lublin, Warsaw, Chorzów, Lodz, Ostrowiec Świętokrzyski
2025-12-02
Not yet open
15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
NCT07237204Liver Cancer, Adult, Metastases to Liver, Liver Malignant Tumors
Medical University of Warsaw
Not applicable
600
Warsaw
2025-12-01
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Lodz, Poznan, Przemyśl, Siedlce, Warsaw
2025-11-30
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 2
78
Gdansk, Krakow, Warsaw
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Skórzewo, Bydgoszcz, Krakow, Siedlce, Warsaw, Przemyśl, Koszalin
2025-11-26
Recruiting
Chong Kun Dang Pharmaceutical
Phase 1
213
Warsaw
2025-11-26
Recruiting
AbbVie
Phase 2
180
Poznan, Lublin, Warsaw
2025-11-25
Recruiting
PhenoNet, Inc.
Phase 2
105
Krakow, Warsaw
2025-11-25
Active, closed
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-11-25
Recruiting
SAb Biotherapeutics, Inc.
Phase 2
159
Opole, Poznan, Warsaw
2025-11-25
Active, closed
Kymera Therapeutics, Inc.
Phase 2
200
Chorzów, Gdansk, Gdynia, Krakow, Lublin, Rzeszów, Szczecin, Warsaw
2025-11-24
Recruiting
Cardiovascular Assessment 5 Years After MIS-C
NCT07659847Multisystem Inflammatory Syndrome in Children (MIS-C), SARS-CoV-2 Infection
Medical University of Warsaw
Observational
90
Warsaw
2025-11-22
Recruiting
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
NCT07593352IBD and Renal Involement, Chronic Kidney Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Observational
6,000
Warsaw
2025-11-20
Active, closed
Bayer
Phase 2
60
Poznan, Warsaw
2025-11-19
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Katowice, Warsaw, Wroclaw
2025-11-19
Recruiting
Bayer
Phase 3
111
Wroclaw, Warsaw, Katowice, Lódz
2025-11-19
Recruiting
Summit Therapeutics
Phase 3
900
Rzeszów, Gdansk, Olsztyn, Otwock, Warsaw
2025-11-18
Active, closed
Pfizer
Phase 2
128
Wroclaw, Gdansk, Ostrowiec Świętokrzyski, Sosnowiec, Szczecin, Warsaw
2025-11-13
Active, closed
Novartis Pharmaceuticals
Phase 2
34
Gdansk, Torun, Warsaw
2025-11-10
Recruiting
Eli Lilly and Company
Phase 2
252
Katowice, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Zamość
2025-11-10
Recruiting
Sanofi
Phase 2
208
Wroclaw, Lodz, Warsaw
2025-11-06
Active, closed
Novo Nordisk A/S
Phase 3
300
Bialystok, Katowice, Lublin, Warsaw
2025-11-05
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Krakow, Wroclaw, Warsaw, Otwock, Rzeszów, Gdansk, Brzozów, Lodz
2025-11-03
Active, closed
Takeda
Phase 2
207
Osielsko, Wroclaw, Szczecin, Katowice, Rzeszów, Warsaw, Lodz, Kielce
2025-11-03
Recruiting
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Not applicable
75
Warsaw
2025-11-01
Recruiting
AstraZeneca
Phase 3
400
Lodz, Olsztyn, Poznan, Warsaw
2025-10-31
Recruiting
Pfizer
Phase 2
200
Warsaw, Chorzów, Gdansk, Lublin, Tarnów, Wroclaw
2025-10-30
Recruiting
BioNTech SE
Phase 3
558
Chorzów, Gdansk, Krakow, Lodz, Lublin, Poznan, Warsaw
2025-10-30
By invitation
Żelazna Medical Centre, LLC
Observational
359
Warsaw
2025-10-28
Recruiting
Takeda
Phase 3
70
Rzeszów, Warsaw
2025-10-27
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Bydgoszcz, Katowice, Lublin, Warsaw
2025-10-27
Recruiting
Hoffmann-La Roche
Phase 3
600
Bystra, Gda?sk, Krakow, Lublin, Olsztyn, Poznan, Radom, Warsaw
2025-10-24
Recruiting
Novo Nordisk A/S
Phase 1
30
Bialystok, Gdansk, Katowice, Lublin, Poznan, Warsaw
2025-10-23
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Poznan, Warsaw, Gdansk, Gdask
2025-10-23
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Warsaw
2025-10-17
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bialystok, Gdansk, Katowice, Lodz, Mysłowice, Poznan, Rzeszów, Warsaw
2025-10-15
Recruiting
Nurix Therapeutics, Inc.
Phase 2
100
Katowice, Krakow, Skorzewo, Warsaw
2025-10-15
Recruiting
Sanofi
Phase 2
54
Bydgoszcz, Warsaw
2025-10-14
Recruiting
Bristol-Myers Squibb
Phase 3
424
Warsaw, Bialystok, Gdansk, Rybnik, Tuszyn
2025-10-08
Active, closed
Merck Sharp & Dohme LLC
Phase 2
185
Bydgoszcz, Torun, Lublin, Warsaw, Bytom
2025-10-08
Recruiting
Lifordi Immunotherapeutics, Inc.
Phase 1
176
Torun, Warsaw
2025-10-06
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Katowice, Warsaw, Wroclaw
2025-10-06
Recruiting
Hoffmann-La Roche
Phase 2
12
Gdansk, Poznan, Warsaw
2025-10-06
Recruiting
Pfizer
Phase 2/3
982
Warsaw, Olsztyn, Koszalin, Poznan, Tomaszów Mazowiecki
2025-10-03
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Gdansk, Poznan, Warsaw
2025-10-02
Not yet open
POPQ Associated With Total Laparoscopic Hysterectomy
NCT07137299Uterine Fibroids (UF), Abnormal Uterine Bleeding Unrelated to Menstrual Cycle, Endometrial Hyperplasia, Pelvic Organ Prolapse (POP)
Medical University of Silesia
Observational
2,000
Katowice, Warsaw
2025-10-01
Recruiting
Casper Rokx
Not applicable
5,200
Janów Lubelski, Kielce, Warsaw
2025-10-01
Recruiting
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
NCT07488754Glioblastoma, High-Grade Glioma (WHO III-IV), Glioblastoma (GBM)
Medical University of Warsaw
Not applicable
35
Warsaw
2025-10-01
Active, closed
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
NCT07210463Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs, Acetylcholine Release Inhibitors
DrugXeomin
Merz Aesthetics GmbH
Phase 3
300
Krakow, Oświęcim, Lublin, Warsaw, Bialystok, Gdynia, Lodz, Ostrowiec Świętokrzyski
2025-10-01
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bydgoszcz, Skórzewo, Szczecin, Warsaw, Wroclaw
2025-09-30
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bydgoszcz, Lodz, Rzeszów, Warsaw
2025-09-29
Recruiting
Merck Sharp & Dohme LLC
Phase 2
315
Bydgoszcz, Torun, Lublin, Warsaw
2025-09-26
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Poznan, Torun, Wroclaw, Lublin, Puławy, Warsaw, Rzeszów, Bialystok
2025-09-22
Active, closed
Bristol-Myers Squibb
Phase 2
76
Warsaw, Prabuty, Lodz
2025-09-19
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Bydgoszcz, Katowice, Krakow, Lublin, Rzeszów, Warsaw, Wroc?aw, Zabrze
2025-09-17
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Krakow, Warsaw
2025-09-17
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Katowice, Krakow, Warsaw
2025-09-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Skórzewo, Biała Podlaska, Warsaw, Opole, Lodz
2025-09-11
Recruiting
LEO Pharma
Phase 2
135
Bialystok, Iwonicz-Zdrój, Lodz, Lublin, Rzeszów, Warsaw, Wroclaw
2025-09-11
Recruiting
Pfizer
Phase 3
140
Krakow, Wroclaw, Lublin, Warsaw, Katowice, Rzeszów, Lodz
2025-09-10
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Bielsko-Biala, Krakow, Otwock, Poznan, Rzeszów, Skorzewo, Tomaszów Mazowiecki, Warsaw
2025-09-08
Recruiting
Dawid Madej
Not applicable
150
Warsaw
2025-09-05
Recruiting
BeOne Medicines
Phase 3
500
Gdansk, Kielce, Lodz, Lublin, Olsztyn, Torun, Warsaw, Wroclaw
2025-09-04
Recruiting
NTC srl
Phase 3
412
Tychy, Warsaw
2025-09-02
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bialystok, Bydgoszcz, Koszalin, Warsaw
2025-09-02
Recruiting
Ocus Innovation Ireland Limited
Phase 3
234
Warsaw
2025-09-01
Recruiting
Medical University of Warsaw
Phase 4
78
Warsaw
2025-09
Not yet open
Medical University of Warsaw
Not applicable
39
Warsaw
2025-09
Not yet open
Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant
NCT07070167Lung Ultrasound, Respiratory Distress Syndrome, Newborn
Chiesi Poland Sp. z o.o.
Observational
200
Krakow, Warsaw
2025-08-30
Recruiting
Meyer Children's Hospital IRCCS
Phase 3
40
Warsaw
2025-08-29
By invitation
Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass
NCT07078370Coronary Artery Disease, Multi Vessel Coronary Artery Disease
Vascudyne, Inc.
Not applicable
20
Poznan, Szczecin, Warsaw
2025-08-28
Recruiting
BeOne Medicines
Phase 3
351
Krakow, Opole, Warsaw
2025-08-27
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Konin, Krakow, Lublin, Poznan, Rzeszów, Warsaw
2025-08-26
Active, closed
Triveni Bio
Phase 2
95
Wroclaw, Warsaw, Chorzów, Katowice, Poznan, Sosnowiec
2025-08-26
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Rzeszów, Szczecin, Warsaw
2025-08-22
Active, closed
A Study of SPY072 in Rheumatic Disease
NCT07148414Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Rheumatic Diseases
DrugSPY072
Spyre Therapeutics, Inc.
Phase 2
285
Krakow, Nowa Sól, Lodz, Warsaw, Opole, Gdynia, Warszawa, Elblag
2025-08-21
Recruiting
AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography
NCT07144189Low-gradient Aortic Stenosis, Aortic Stenosis
National Institute of Cardiology, Warsaw, Poland
Observational
300
Warsaw
2025-08-20
Active, closed
Hoffmann-La Roche
Phase 2
330
Bialystok, Gdansk, Bydgoszcz, Katowice, Lublin, Tarnów, Warsaw, Wroclaw
2025-08-19
Active, closed
Amgen
Phase 3
350
Bystra, Gdansk, Warsaw
2025-08-18
Recruiting
Maria Sklodowska-Curie National Research Institute of Oncology
Not applicable
225
Warsaw
2025-08-15
Recruiting
Medical University of Warsaw
Observational
100
Warsaw
2025-08-15
Recruiting
Takeda
Phase 3
150
Bydgoszcz, Warsaw, Katowice, Lodz
2025-08-14
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Krakow, Wroclaw, Warsaw
2025-08-11
Recruiting
Sanofi
Phase 3
723
Lublin, Lodz, Warsaw, Bialystok
2025-08-06
Recruiting
AstraZeneca
Phase 3
700
Gdynia, Gliwice, Koszalin, Krakow, Piotrkow Trybunalski, Poznan, Rzeszów, Warsaw
2025-08-06
Recruiting
Pfizer
Phase 3
400
Bydgoszcz, Krakow, Wroclaw, Warsaw, Opole
2025-08-05
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919Liver Transplantation, HCC, Oncological Outcomes
Philipp Dutkowski
Phase 4
220
Gdansk, Warsaw
2025-08-01
Recruiting
DCB vs. DES in Bifurcation Coronary Lesions
NCT06551662Coronary Artery Disease, DCB
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
321
Gdansk, Katowice, Krakow, Lubin, Lublin, Poznan, Rzeszów, Warsaw
2025-08-01
Recruiting
Crystalys Therapeutics
Phase 3
500
Poznan, Krakow, Wroclaw, Plońsk, Sochaczew, Warsaw, Bialystok, Gdynia
2025-08-01
Not yet open
Medical University of Warsaw
Not applicable
39
Warsaw
2025-08
Active, closed
Pfizer
Phase 3
208
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Ossy, Rzeszów
2025-07-31
Recruiting
Medical University of Warsaw
Observational
100
Warsaw
2025-07-30
Recruiting
Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI
NCT06878729Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention
National Institute of Cardiology, Warsaw, Poland
Not applicable
74
Warsaw, Lublin
2025-07-28
Recruiting
AbbVie
Phase 3
120
Warsaw, Bialystok
2025-07-28
Recruiting
Celgene
Phase 3
400
Skórzewo, Krakow, Warsaw, Gdynia, Lodz
2025-07-28
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Warsaw
2025-07-25
Recruiting
Celcuity Inc
Phase 3
1,180
Siedlce, Bydgoszcz, Konin, Krakow, Lodz, Opole, Szczecin, Warsaw
2025-07-24
Recruiting
Pfizer
Phase 3
150
Krakow, Lublin, Warsaw, Chorzów, Katowice, Lodz, Ostrowiec Świętokrzyski
2025-07-24
Recruiting
AbbVie
Phase 1/2
325
Poznan, Lublin, Warsaw
2025-07-23
Recruiting
Pfizer
Phase 3
714
Poznan, Lublin, Warsaw, Gdansk, Gliwice, Lodz
2025-07-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bydgoszcz, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin, Lodz
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Gliwice, Katowice, Krakow, Warsaw, Wroclaw
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Bydgoszcz, Warsaw, Gdansk
2025-07-20
Recruiting
Bristol-Myers Squibb
Phase 3
450
Poznan, Warsaw, Bialystok, Gdansk, Rybnik, Tuszyn
2025-07-18
Recruiting
AstraZeneca
Phase 2
100
Bialystok, Warsaw
2025-07-17
Recruiting
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
NCT07017933Renal Impairment After Cardiac Surgery, Renal Impairment, Acute Kidney Injury
3ive Labs
Not applicable
124
Bielsko-Biala, Poznan, Warsaw
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Poznan, Warsaw, Rzeszów, Gliwice, Koszalin
2025-07-16
By invitation
Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
NCT07117240Steroid-Induced Diabetes, Steroid-Induced Hyperglycemia, Diabetes
Medical University of Warsaw
Phase 4
100
Warsaw
2025-07-10
Recruiting
National Institute of Cardiology, Warsaw, Poland
Phase 4
300
Warsaw
2025-07-10
Active, closed
Glycomine, Inc.
Phase 2/3
50
Warsaw
2025-07-09
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA
Artiva Biotherapeutics, Inc.
Phase 2
90
Bydgoszcz, Warsaw
2025-07-09
Recruiting
Helsinn Healthcare SA
Phase 2
95
Bialystok, Bydgoszcz, Lodz, Lublin, Olsztyn, Poznan, Szczecin, Warsaw
2025-07-07
Active, closed
Sanofi
Phase 2
105
Wroclaw, Bydgoszcz, Chojnice, Katowice, Sopot, Tychy, Warsaw
2025-07-07
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Poznan, Warsaw, Gdansk, Koszalin
2025-07-03
Recruiting
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Phase 3
86
Warsaw
2025-07-01
Not yet open
Medical University of Warsaw
Not applicable
94
Warsaw
2025-07
Not yet open
Early Supplementation for Cow's Milk Allergy Prevention
NCT06652698Food Allergy, Cow's Milk Allergy
Medical University of Warsaw
Not applicable
1,000
Warsaw
2025-07
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Bydgoszcz, Krakow, Wałbrzych, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Biała Podlaska, Bielsko-Biala, Krakow, Przemyśl, Warsaw
2025-06-30
Recruiting
Ipsen
Phase 2
132
Katowice, Krakow, Oświęcim, Pabianice, Warsaw, Wroclaw
2025-06-30
Not yet open
Prophylactic Suture Line Sealing With NE'X Glue R-eco in Cardiac and Vascular Surgery
NCT06918496Aortic Aneurysm, Aortic Aneurysm Abdominal, Valve Stenoses, Aortic, Valve Regurgitation, Mitral
Grena Biomed Limited
Not applicable
60
Warsaw
2025-06-30
Active, closed
Immunovant Sciences GmbH
Phase 2
180
Bydgoszcz, Krakow, Lodz, Lublin, Poznan, Siedlce, Warsaw, Wołomin
2025-06-30
Recruiting
Hoffmann-La Roche
Phase 3
75
Warsaw
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
350
Katowice, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Lublin, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Recruiting
Medical University of Warsaw
Not applicable
104
Warsaw
2025-06-24
Active, closed
Incyte Corporation
Phase 3
580
Lodz, Torun, Warsaw, Wroclaw
2025-06-23
Active, closed
ResearchSkills
Observational
200
Katowice, Poznan, Ruda Śląska, Rzeszów, Warsaw
2025-06-21
Recruiting
AbbVie
Phase 2
180
Bydgoszcz, Krakow, Warsaw, Elblag, Olsztyn
2025-06-20
By invitation
Predictive Factors and Monitoring Strategies in Steroid-Induced Diabetes
NCT07190378Steroid-Induced Diabetes, Diabete Type 2, Steroid Induced Hyperglycemia
Medical University of Warsaw
Observational
250
Warsaw
2025-06-20
Active, closed
VahatiCor, Inc.
Not applicable
30
Warsaw
2025-06-18
Active, closed
AbbVie
Phase 3
573
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw, Chojnice, Bytom, Szczecin
2025-06-17
Active, closed
Incyte Corporation
Phase 3
159
Gdansk, Katowice, Krakow, Lodz, Lublin, Szczecin, Torun, Warsaw
2025-06-17
Recruiting
GlaxoSmithKline
Phase 1/2
346
Brzozów, Koszalin, Warsaw
2025-06-11
Recruiting
Bristol-Myers Squibb
Phase 3
274
Poznan, Warsaw, Bialystok, Gdansk, Rybnik, Sosnowiec, Tuszyn
2025-06-11
Active, closed
Sandoz
Phase 3
183
Bydgoszcz, Katowice, Lodz, Lublin, Nowa Sól, Poznan, Szczecin, Warsaw
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Bialystok, Chorzów, Piaseczno, Rzeszów, Warsaw, Wołomin
2025-06-09
Recruiting
Celgene
Phase 2
200
Bydgoszcz, Krakow, Oświęcim, Warsaw, Katowice, Gdansk, Słomniki, Lodz
2025-06-05
Recruiting
GlaxoSmithKline
Phase 2
80
Chorzów, Warsaw
2025-06-05
Recruiting
Boehringer Ingelheim
Phase 2
300
Bielsko-Biala, Bydgoszcz, Katowice, Krakow, Olsztyn, Poznan, Tarnowskie Góry, Warsaw
2025-06-05
Recruiting
Sanofi
Phase 2
99
Wroclaw, Krakow, Lublin, Sopot, Warsaw
2025-06-03
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugSofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Krakow, Kłodzko, Lublin, Mysłowice, Warsaw, Wroclaw
2025-06-02
Recruiting
Odyssey Therapeutics, Inc.
Phase 2
57
Bydgoszcz, Chojnice, Katowice, Rzeszów, Sopot, Staszów, Warsaw, Wroclaw
2025-06-02
Recruiting
"Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant"
NCT07288281Preoperative Clear Fluid Fasting, Liver Transplant Recipient
Medical University of Warsaw
Observational
100
Warsaw
2025-06-01
Not yet open
Stomach Processing and Emptying Evaluation With Diet and Ultrasound
NCT06988397Gastric Emptying, Preoperative Risk Assessment, Healthy Volunteer Study
Medical University of Warsaw
Not applicable
60
Warsaw
2025-06-01
Active, closed
Institute of Sport - National Research Institute, Poland
Not applicable
20
Warsaw
2025-06-01
Recruiting
MediWound Ltd
Phase 3
216
Krakow, Lublin, Warsaw, Bialystok, Siemianowice Śląskie, Tychy, Lodz, Nowy Targ
2025-06-01
Not yet open
Leibniz-Institut für Resilienzforschung (LIR) gGmbH
Not applicable
122
Warsaw
2025-06
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Gdansk, Gliwice, Krakow, Poznan, Warsaw
2025-05-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
160
Poznan, Warsaw
2025-05-29
Recruiting
Chiesi Poland Sp. z o.o.
Observational
120
Gdansk, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2025-05-29
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Poznan, Warsaw, Gdansk, Koszalin
2025-05-28
Recruiting
Takeda
Phase 2
192
Torun, Lublin, Szczecin, Warsaw
2025-05-28
Recruiting
Immunovant Sciences GmbH
Phase 3
231
Gdansk, Katowice, Krakow, Lublin, Warsaw
2025-05-27
Recruiting
Intelligent Lung Support in the Intensive Care Unit
NCT06595602Mechanical Ventilation, Intensive Care Medicine
Technische Universität Dresden
Observational
530
Warsaw
2025-05-25
Recruiting
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 2
44
Poznan, Rzeszów, Warsaw
2025-05-22
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Lubin, Warsaw, Brzozów, Gliwice, Olsztyn, Przemyśl, Swidnica
2025-05-22
Recruiting
Eikon Therapeutics
Phase 2/3
740
Gdansk, Konin, Siedlce, Gliwice, Warsaw
2025-05-22
Active, closed
Sanofi
Phase 3
1,092
Bydgoszcz, Torun, Krakow, Trzebnica, Wroclaw, Warsaw, Łomianki, Siemianowice Śląskie
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Poznan, Siedlce, Warsaw, Bialystok, Gdansk, Gliwice, Kielce
2025-05-22
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
NCT06876649Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
DrugPirtobrutinib
Eli Lilly and Company
Phase 4
787
Krakow, Warsaw
2025-05-20
Recruiting
Eli Lilly and Company
Phase 4
279
Krakow, Warsaw
2025-05-20
Recruiting
SecuraBio
Phase 3
124
Gdansk, Krakow, Warsaw
2025-05-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Bydgoszcz, Gdansk, Poznan, Warsaw
2025-05-19
Active, closed
Zura Bio Inc
Phase 2
247
Bialystok, Katowice, Malbork, Poznan, Szczecin, Warsaw
2025-05-16
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Warsaw, Katowice, Lodz, Lublin
2025-05-16
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361Symptomatic Severe Aortic Stenosis
Ceric Sàrl
Not applicable
1,180
Poznan, Szczecin, Warsaw, Wroclaw
2025-05-15
Recruiting
Apogee Therapeutics, Inc.
Phase 2
350
Wroclaw, Lublin, Warsaw, Gdansk, Katowice, Sosnowiec, Szczecin, Krakow
2025-05-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
96
Poznan, Warsaw, Gdansk, Koszalin
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Poznan, Bydgoszcz, Krakow, Siedlce, Warsaw, Katowice
2025-05-13
Recruiting
Casa di Cura IGEA
Observational
1,200
Warsaw
2025-05-12
Recruiting
Coronary Sinus Reducer in Patients With Angina With no Obstructive Coronary Disease
NCT07010029Angina With No Obstructive Coronary Artery Disease, ANOCA, Coronary Sinus Reducer
Medical University of Warsaw
Not applicable
50
Warsaw
2025-05-12
Active, closed
Sanofi
Phase 2
71
Poznan, Krakow, Wroclaw, Warsaw, Katowice
2025-05-12
Recruiting
Takeda
Phase 3
59
Krakow, Lublin, Warsaw, Gdansk
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Bydgoszcz, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
2025-05-06
Active, closed
Hoffmann-La Roche
Phase 2
285
Krakow, Gdansk, Lublin, Warsaw
2025-05-05
Active, closed
PICC Inserted by a Nurse-led Vascular Access Team in Poland
NCT06979128Vascular Access, PICC Line Placement
Medical University of Warsaw
Observational
200
Warsaw
2025-05-05
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Hoffmann-La Roche
Observational
44
Warsaw
2025-04-29
Recruiting
Children's Memorial Health Institute, Poland
Not applicable
40
Warsaw
2025-04-25
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2
83
Poznan, Wroclaw, Siedlce, Warsaw, Wołomin, Bydgoszcz, Katowice, Lublin
2025-04-23
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT06512883Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
14
Kielce, Warsaw
2025-04-17
Recruiting
Hoffmann-La Roche
Not applicable
270
Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
2025-04-14
Recruiting
AbbVie
Phase 2
300
Bydgoszcz, Pruszków, Warsaw, Bialystok, Elblag
2025-04-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Skórzewo, Krakow, Nowy Sącz, Wałbrzych, Warsaw, Gdansk, Katowice
2025-04-11
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
400
Bialystok, Warsaw
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Poznan, Warsaw, Bialystok, Szczecin, Kielce
2025-04-09
Recruiting
Epygenix
Phase 3
260
Krakow, Wroclaw, Warsaw
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Elblag, Gdynia, Katowice, Krakow, Lodz, Malbork, Szczecin, Warsaw
2025-04-09
Active, closed
UCB Biopharma SRL
Phase 3
43
Lodz, Warsaw, Wroclaw
2025-04-07
Active, closed
Hoffmann-La Roche
Phase 2
30
Gdansk, Lodz, Warsaw
2025-04-04
Recruiting
Gilead Sciences
Phase 3
695
Lodz, Poznan, Rzeszów, Siedlce, Stupsk, Warsaw
2025-04-04
Active, closed
Philip Morris Products S.A.
Not applicable
290
Bialystok, Kajetany, Krakow, Lodz, Sochaczew, Warsaw, Wroclaw
2025-04-02
Recruiting
University of Warsaw
Not applicable
78
Warsaw
2025-04-01
Active, closed
Hoffmann-La Roche
Phase 2
162
Gdynia, Katowice, Krakow, Rzeszów, Warsaw
2025-04-01
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Warsaw
2025-03-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2
90
Poznan, Warsaw, Gdansk, Koszalin
2025-03-30
Recruiting
Eli Lilly and Company
Phase 2
200
Bialystok, Gdansk, Krakow, Lodz, Lublin, Tarnów, Warsaw, Wroclaw
2025-03-28
Recruiting
Daiichi Sankyo
Phase 3
510
Lublin, Siedlce, Warsaw
2025-03-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Poznan, Krakow, Warsaw, Koszalin
2025-03-25
Recruiting
Wissenschaftliches Institut Bethanien e.V
Observational
1,800
Warsaw
2025-03-24
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
206
Wroclaw, Lublin, Krakow, Rzeszw, Malbork, Bialystok-Podlaskie, Katowice, Warsaw
2025-03-21
Active, closed
Immutep S.A.S.
Phase 3
756
Gdynia, Konin, Lodz, Warsaw
2025-03-21
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Warsaw
2025-03-20
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Krakow, Lodz, Rzeszów, Warsaw
2025-03-20
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Poznan, Warsaw, Gdansk
2025-03-20
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Lublin, Bydgoszcz, Gdansk, Katowice, Krakow, Poznan, Warsaw
2025-03-18
Not yet open
EPidural's Impact on Contractions and Fetal REsponse
NCT06860854Epidural Anesthesia in Labor and Delivery, Doppler Ultrasound, Uterine Contraction
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Observational
200
Warsaw
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Poznan, Bydgoszcz, Krakow, Siedlce, Warsaw, Wieliszew, Bialystok, Gdynia
2025-03-16
Active, closed
Celgene
Phase 3
960
Poznan, Wroclaw, Warsaw, Opole, Gdansk, Bytom, Bydgoszcz, Katowice
2025-03-13
Active, closed
Amgen
Phase 3
3,853
Bialystok, Dębica, Gdynia, Katowice, Lodz, Lublin, Poznan, Warsaw
2025-03-12
Recruiting
Moleculin Biotech, Inc.
Phase 2/3
312
Olsztyn, Poznan, Szczecin, Torun, Warsaw
2025-03-12
Recruiting
Pfizer
Phase 3
723
Krakow, Oświęcim, Wroclaw, Lublin, Warsaw, Katowice
2025-03-11
Active, closed
Takeda
Phase 3
601
Bydgoszcz, Krakow, Wroclaw, Gdynia, Częstochowa, Elblag, Poznan, Warsaw
2025-03-10
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Opole, Warsaw, Wroclaw
2025-03-10
Recruiting
Medical University of Warsaw
Phase 2
105
Warsaw
2025-03-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
Bialystok, Gliwice, Józefów, Warsaw
2025-03-04
Active, closed
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
NCT06845202Obese or Overweight Healthy Volunteers, Type 2 Diabetes Mellitus (T2DM)
DrugALN-4324
Alnylam Pharmaceuticals
Phase 1/2
105
Gdansk, Tarnów, Warsaw, Wroclaw
2025-03-03
Recruiting
Takeda
Phase 3
1,088
Poznan, Krakow, Katowice, Sochaczew, Warsaw, Opole, Bialystok, Bytom
2025-03-03
Recruiting
Medical University of Warsaw
Observational
80
Warsaw
2025-03-01
Recruiting
AstraZeneca
Phase 3
840
Bialystok, Gdansk, Koszalin, Lodz, Olsztyn, Przemyśl, Tomaszów Mazowiecki, Warsaw
2025-03-01
Not yet open
University Hospital, Antwerp
Observational
120
Warsaw
2025-03
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,268
Lodz, Warsaw, Częstochowa, Bydgoszcz, Kłodzko, Torun
2025-02-28
Recruiting
Takeda
Phase 3
171
Bydgoszcz, Warsaw, Katowice, Lodz
2025-02-27
Recruiting
Bambusa Therapeutics
Phase 1
237
Lodz, Rzeszów, Warsaw, Wroclaw
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Bielsko-Biala, Koszalin, Poznan, Warsaw
2025-02-27
Recruiting
Amgen
Phase 3
844
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz
2025-02-25
Recruiting
UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
NCT06590961Relapsed/Refractory B-cell Malignancies
Ubix Therapeutics, Inc.
Phase 1
94
Torun, Warsaw, Katowice, Grodzisk Wielkopolski
2025-02-20
Active, closed
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
NCT06980805Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
DrugIMVT-1402
Immunovant Sciences GmbH
Phase 2
56
Poznan, Gorzów Wielkopolski, Warsaw, Rzeszów, Lodz
2025-02-19
Recruiting
Menarini Group
Phase 2
44
Lodz, Warsaw
2025-02-18
Recruiting
AbbVie
Phase 3
420
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw
2025-02-13
Active, closed
Sanofi
Phase 3
231
Krakow, Wroclaw, Lublin, Warsaw, Bialystok
2025-02-12
Recruiting
Janssen Research & Development, LLC
Phase 3
50
Lodz, Warsaw
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Bydgoszcz, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2025-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Lublin, Krakow, Bydgoszcz, Katowice, Lodz, Poznan, Skorzewo, Warsaw
2025-02-07
Active, closed
Zura Bio Inc
Phase 2
80
Chorzów, Krakow, Lodz, Nowa Sól, Poznan, Warsaw, Zabrze
2025-02-06
Recruiting
LEO Pharma
Phase 3
90
Warsaw, Wroclaw
2025-02-05
Active, closed
Viridian Therapeutics, Inc.
Phase 3
320
Bialystok, Gdansk, Gdynia, Lodz, Lublin, Piaseczno, Warsaw
2025-02-03
Active, closed
Józef Piłsudski University of Physical Education
Observational
20
Warsaw
2025-02-03
Recruiting
Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)
NCT07240441Ventricular Tachycardias, Myocardial Infarction (MI), Implantable Cardiac Defibrillator, Ablation
MEDICOVER SP Z O.O.
Not applicable
220
Warsaw, Bydgoszcz, Gdansk, Krakow, Poznan, Szczecin
2025-02-03
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Gdansk, Gliwice, Katowice, Konin, Krakow, Siedlce, Warsaw
2025-01-28
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
NCT06833749Osteoarthritis in the Knee, Obesity
KeyBioscience AG
Phase 2
600
Bytom, Poznan, Swidnica, Warsaw, Wroclaw
2025-01-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Wroclaw, Lublin, Warsaw, Słupsk, Gliwice, Katowice, Olsztyn
2025-01-27
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Gdansk, Lodz, Olsztyn, Warsaw
2025-01-22
Recruiting
Takeda
Phase 3
70
Warsaw, Rzeszów, Zabrze
2025-01-22
Recruiting
Pfizer
Phase 3
211
Warsaw, Bialystok
2025-01-22
Active, closed
AbbVie
Phase 2
150
Skórzewo, Warsaw
2025-01-20
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
Bydgoszcz, Katowice, Lublin, Warsaw
2025-01-17
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bydgoszcz, Katowice, Kielce, Krakow, Lodz, Lublin, Poznan, Warsaw
2025-01-13
Active, closed
Immunovant Sciences GmbH
Phase 2
120
Bialystok, Elblag, Lublin, Nadarzyn, Poznan, Sochaczew, Warsaw, Wroclaw
2025-01-10
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Podlaski, Bydgoszcz, Wroclaw, Krakow, Sochaczew, Warsaw, Bialystok, Gdansk
2025-01-08
By invitation
Can Blood Biomarkers of Inflammation and BDNF be Used to Assess the Effectiveness of Collagen Mesotherapy in Chronic CMPS?
NCT06807177Myofascial Pain Syndrome - Neck, Spondyloarthrosis, Neck Pain, Cervical Pain
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Observational
40
Warsaw
2025-01-08
Recruiting
Sensor Cliniq
Observational
300
Warsaw
2025-01-02
Recruiting
Takeda
Phase 3
396
Lodz, Poznan, Tychy, Warsaw
2025-01-02
Recruiting
ctDNA Monitoring in Patients With HCC and mCRC
NCT07001085HCC - Hepatocellular Carcinoma, Colorectal Cancer Metastatic
Medical University of Warsaw
Not applicable
300
Warsaw
2025-01-01
Recruiting
Medical University of Warsaw
Not applicable
360
Warsaw
2024-12-31
Active, closed
Boehringer Ingelheim
Phase 2
90
Warsaw
2024-12-30
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
216
Krakow, Warsaw, Gdynia, Sopot, Katowice, Lublin
2024-12-30
Recruiting
Santen SAS
Phase 3
234
Gdansk, Katowice, Warsaw
2024-12-30
Recruiting
Cytokinetics
Phase 3
1,800
Warsaw, Bialystok, Krakow, Lodz, Miechów, Opole, Poznan, Ruda Śląska
2024-12-19
Active, closed
argenx
Phase 3
154
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2024-12-18
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Gliwice, Krakow, Lublin, Poznan, Warsaw
2024-12-17
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Bydgoszcz, Bystra, Gdansk, Olsztyn, Warsaw
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
520
Lodz, Lublin, Warsaw, Wałbrzych
2024-12-16
Active, closed
AstraZeneca
Phase 2
24
Warsaw
2024-12-11
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Warsaw
2024-12-09
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Bydgoszcz, Dębica, Krakow, Lublin, Olsztyn, Poznan, Siedlce, Warsaw
2024-12-04
Recruiting
Medical University of Warsaw
Not applicable
92
Warsaw
2024-12-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw, Gdynia, Bielsko-Biala, Katowice
2024-12-02
By invitation
Chronic Abdominal Pain After Laparoscopic Sleeve Gastrectomy
NCT06686875Obesity, Chronic Pain, Abdominal Pain
Medical University of Warsaw
Observational
200
Warsaw
2024-12-01
Recruiting
BeOne Medicines
Phase 1/2
80
Gdansk, Lublin, Olsztyn, Opole, Warsaw
2024-11-27
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
400
Bydgoszcz, Krakow, Lublin, Olsztyn, Tarnów, Warsaw
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Bialystok, Biała Podlaska, Bydgoszcz, Bystra, Lodz, Lublin, Poznan, Warsaw
2024-11-27
Recruiting
GlaxoSmithKline
Phase 3
750
Bydgoszcz, Trzebnica, Warsaw
2024-11-26
Active, closed
Genmab
Phase 3
191
Koszalin, Krakow, Lodz, Skorzewo, Warsaw
2024-11-25
Rows per page Showing 1–500 of 1318
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-poland/city/warsaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,709 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,318 of those studies with a site in Warsaw.

How many clinical trials are recruiting in Warsaw?

629 of the 1,318 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 46 have not yet opened recruitment, 607 are active but closed to new participants, and 36 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Warsaw), 1,318 studies
PhaseStudiesRecruitingShare
Phase 365927050%
Phase 22229516.8%
Not applicable1408410.6%
Observational127889.6%
Phase 2/350303.8%
Phase 1/248263.6%
Phase 142213.2%
Phase 429142.2%
Early Phase 1110.1%

Most active sponsors

Lead sponsors with the most studies (Warsaw)
Lead sponsorStudiesRecruiting
AstraZeneca9539
Merck Sharp & Dohme LLC8744
Medical University of Warsaw6844
Hoffmann-La Roche6018
Janssen Research & Development, LLC4414
AbbVie3913
Eli Lilly and Company3624
Pfizer3118
Bristol-Myers Squibb3015
Novartis Pharmaceuticals2810
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.